Osmotica Pharmaceuticals 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1JanExpected
Q4 0
-0.02
0.32
0.65
0.98
Expected EPS
-0.015176
Actual EPS
N/A

Financials

-105.6%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
46.79MRevenue
-49.41MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

RVL PHARMACEUTICALS PLC
Show more...
CEO
Brian A. Markison
Employees
125
Country
Ireland
ISIN
IE00BF2HDL56
WKN
000A2N6WE

Listings

0 Comments

Share your thoughts

FAQ

What is Osmotica Pharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Osmotica Pharmaceuticals stocks are traded under the ticker O1P.STU.
What is Osmotica Pharmaceuticals revenue for the last year?
Osmotica Pharmaceuticals revenue for the last year amounts to 46.79M EUR.
What is Osmotica Pharmaceuticals net income for the last year?
O1P.STU net income for the last year is -49.41M EUR.
How many employees does Osmotica Pharmaceuticals have?
As of September 05, 2026, the company has 125 employees.
In which sector is Osmotica Pharmaceuticals located?
Osmotica Pharmaceuticals operates in the Health & Wellness sector.
When did Osmotica Pharmaceuticals complete a stock split?
Osmotica Pharmaceuticals has not had any recent stock splits.
Where is Osmotica Pharmaceuticals headquartered?
Osmotica Pharmaceuticals is headquartered in Bridgewater, Ireland.